José Ignacio Fernández-Velasco

Author

Hospital Universitario Ramón y Cajal ORCID

Also Known As

J. I. Fernández Velasco, Jose I Fernández-Velasco, Jose I. Fernandez-Velasco, Jose Ignacio Fernandez Velasco, Jose Ignacio Fernandez-Velasco, Jose Ignacio Fernández-Velasco, José I. Fernández-Velasco, José Ignacio Fernández Velasco, José Ignacio Fernández-Velasco, Susana Sainz de la Maza

Publications

494

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Ramón y Cajal Instituto Ramón y Cajal de Investigación Sanitaria Spanish Multiple Sclerosis Network Universidad de Alcalá Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

About

José Ignacio Fernández-Velasco is an author at Hospital Universitario Ramón y Cajal specializing in medicine, allergy, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	101
2	Allergy	2	2	42
3	Immunology	2	2	42
4	Public Health	1	1	59
5	Epidemiology	1	1	59

José Ignacio Fernández-Velasco

Publications

396

Citations

H-Index

Page 1

	Year	Citations
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS José Ignacio Fernández-Velasco, Jens Kühle, Enric Monreal, Neurology Neuroimmunology & Neuroinflammation	2021	61
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study Enric Monreal, Susana Sainz de la Maza, Elena Natera‐Villalba, European Journal of Clinical Microbiology & Infectious Diseases Retrospective Cohort StudyLong CovidCovid-19 PandemicClinical EpidemiologySevere Covid-19	2020	59
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs Enric Monreal, José Ignacio Fernández-Velasco, María Isabel García-Sánchez, JAMA Neurology	2023	44
Acetate correlates with disability and immune response in multiple sclerosis Silvia Pérez‐Pérez, María Inmaculada Domínguez‐Mozo, Aitana Alonso-Gómez, PeerJ	2020	39
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome Enric Monreal, Susana Sainz de la Maza, Lucienne Costa‐Frossard, Neurology Neuroimmunology & Neuroinflammation	2021	34
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis Enric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez‐Lafuente, Brain	2024	29
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis Carmen Picón, Amalia Tejeda Velarde, José Ignacio Fernández-Velasco, Frontiers in Immunology ImmunologyImmune RegulationPathologyImmunotherapyImmune System	2021	25
Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study Juan Pablo Cuello, María Luisa Martínez Ginés, Jens Kühle, European Journal of Neurology	2019	24
Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls María Inmaculada Domínguez‐Mozo, Silvia Pérez‐Pérez, Noelia Villarrubia, Cells Herpesvirus AntibodiesImmunologyCell SubsetsImmune SystemVitamin D Levels	2021	17
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability Rocco Capuano, Irati Zubizarreta, Salut Albà-Arbalat, Multiple Sclerosis Journal	2021	17

Page 1